Diabetes is one of the fastest growing disorders affecting population across the globe, where diagnosis remains as big a challenge as treatment. Will Machine Learning enable healthcare companies to develop an effective disease management solution?
WHOOP, a start-up founded out of the Harvard iLab, uses machine learning to improve athletic performance and possibly the lives of diabetes patients.
Medtronic is a first mover in diabetes care with the use of artificial intelligence to improve patient outcomes.
Omada tackles diabetes through a digital therapeutics program that helps patients to change their habits
For diabetes type 2 patients, the app “Bluestar” has been a revolutionary way to manage daily life, making it a great example of the transformative impact of mobile health.
Long the dream of patients with Type-1 Diabetes Mellitus and medical device companies worldwide, Medtronic has taken the closest step yet to creating an “artificial pancreas”
Abbott’s Diabetes Care division is embracing opportunities to integrate digital platforms with patient-centered devices.
Medtronic uses IoT technology to mature its product line and elevate its position in patient care.
Creating the "digital therapeutics" category
Jana Care is an early stage medical technology company leveraging connected devices to address the global diabetes epidemic.